Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INFI [NASD]
Infinity Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own0.20% Shs Outstand48.76M Perf Week-0.28%
Market Cap864.51M Forward P/E- EPS next Y-2.93 Insider Trans-47.43% Shs Float47.80M Perf Month30.46%
Income-10.40M PEG- EPS next Q-1.00 Inst Own94.90% Short Float6.84% Perf Quarter29.04%
Sales160.60M P/S5.38 EPS this Y-55.30% Inst Trans-2.87% Short Ratio4.93 Perf Half Y47.01%
Book/sh5.05 P/B3.51 EPS next Y-498.00% ROA-21.20% Target Price19.00 Perf Year40.60%
Cash/sh7.77 P/C2.28 EPS next 5Y3.00% ROE-27.80% 52W Range8.40 - 18.25 Perf YTD28.39%
Dividend- P/FCF6.79 EPS past 5Y-33.80% ROI- 52W High-2.85% Beta1.10
Dividend %- Quick Ratio6.70 Sales past 5Y- Gross Margin- 52W Low111.07% ATR0.87
Employees180 Current Ratio6.70 Sales Q/Q- Oper. Margin-1.20% RSI (14)65.49 Volatility7.50% 5.54%
OptionableYes Debt/Eq0.00 EPS Q/Q385.90% Profit Margin-32.80% Rel Volume1.72 Prev Close17.19
ShortableYes LT Debt/Eq0.00 EarningsNov 06 AMC Payout- Avg Volume663.12K Price17.73
Recom2.10 SMA2011.48% SMA5023.77% SMA20045.21% Volume1,139,242 Change3.14%
Oct-20-14Resumed Stifel Hold
Mar-06-13Reiterated Stifel Buy $39 → $50
Mar-06-13Reiterated RBC Capital Mkts Outperform $38 → $55
Nov-21-12Initiated RBC Capital Mkts Outperform $28
Aug-24-12Initiated Stifel Nicolaus Hold
Jan-05-12Initiated Rodman & Renshaw Mkt Perform
Apr-16-09Downgrade Roth Capital Hold → Sell $6 → $4
Apr-15-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Dec-11-08Downgrade Roth Capital Neutral → Hold
Nov-20-08Reiterated Rodman & Renshaw Mkt Outperform
Oct-31-08Upgrade Susquehanna Financial Neutral → Positive
Oct-31-08Upgrade Roth Capital Hold → Buy $8 → $6
Jul-31-08Downgrade Roth Capital Buy → Hold $11 → $8
Jun-06-08Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $13
Jan-15-08Initiated Roth Capital Buy $11
Dec-07-07Initiated Susquehanna Financial Neutral
Aug-03-07Upgrade Robert W. Baird Neutral → Outperform $15 → $16
Jul-12-07Initiated Jefferies & Co Buy $15
Jan-30-07Initiated Robert W. Baird Neutral $15
Dec-15-14 07:26PM  Lightning Round: I want this to go lower at CNBC -12.37%
Dec-09-14 11:30AM  Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at the American Society of Hematology Annual Meeting Business Wire
Dec-08-14 10:45AM  Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology Compound Duvelisib at American Society of Hematology Annual Meeting Business Wire
Nov-26-14 10:02AM  Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock at TheStreet
Nov-24-14 08:00AM  Infinity to Present at the Deutsche Bank Securities 2014 BioFEST Conference Business Wire
Nov-18-14 01:04PM  INFINITY PHARMACEUTICALS, INC. Financials EDGAR Online Financials
Nov-14-14 09:39AM  Infinity Pharmaceuticals (INFI) Upgraded From Sell to Hold at TheStreet
Nov-10-14 04:08PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-06-14 05:54PM  Infinity beats 3Q profit forecasts AP
04:30PM  Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:17PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
04:00PM  Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update Business Wire
09:06AM  Infinity Announces Clinical and Preclincal Data for Duvelisib to Be Presented at ASH 2014 Annual Meeting Business Wire
07:07AM  Q3 2014 Infinity Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Nov-05-14 04:10PM  Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? Zacks
04:00PM  Will Synta Pharmaceuticals (SNTA) Post a Wider Q3 Loss? Zacks
Oct-30-14 08:00AM  Infinity to Participate in Four Conferences in November Business Wire
Oct-29-14 11:14AM  3 Health Care Picks To Beat Earnings Zacks
Oct-23-14 08:00AM  Infinity Announces the Date of Its Third Quarter 2014 Financial Results Conference Call and Webcast Business Wire
Oct-17-14 04:00PM  Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study Zacks
Oct-16-14 07:47AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and E EDGAR Online
07:35AM  Infinity Reports Topline Data from Phase 2a Exploratory Study of Duvelisib in Patients with Mild, Allergic Asthma Business Wire
Sep-26-14 08:01AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Sep-22-14 12:59PM  3 Partnerships Pushing The Pharmaceutical Sector Forward Benzinga
Sep-11-14 07:59AM  The Zacks Analyst Blog Highlights: AbbVie, Infinity Pharmaceuticals, Keryx Biopharmaceuticals, Gilead and Amgen Zacks
Sep-10-14 08:30PM  Stock Trading Ideas for 9/10/12 Yahoo Finance Blogs
10:17AM  Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Zacks
Sep-09-14 06:48AM  Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% Zacks
Sep-08-14 01:02PM  Pharmacyclics Price Target Cut On Higher Spending at Investor's Business Daily +7.05%
Sep-04-14 04:10PM  Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? Zacks -8.90%
Sep-03-14 06:36PM  Infinity, AbbVie team on drug Investor's Business Daily +44.05%
06:14PM  Nasdaq stocks posting largest percentage increases AP
06:11PM  Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership Zacks
04:32PM  [video] Stocks Close Mixed on Apple, Tesla Chooses Nevada for 'Gigafactory' at TheStreet
02:10PM  Is Infinity Fully Valued Now, or Is More Upside Left? at 24/7 Wall St.
01:35PM  [video] Infinity Pharma teams up with AbbVie for cancer drug at CNBC
01:20PM  Infinity Pharma JoinsAbbVie On Blood Cancer Drug at Investor's Business Daily
01:10PM  Infinity Up Big on AbbVie Deal, Small Pharma in Focus StockTwits
10:15AM  Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today at TheStreet
09:08AM  Stock Futures Up And Climbing; Baidu Heads China Stock Rally at Investor's Business Daily
08:51AM  Toll Brothers builds up profits; Netflix nabs another TV series; Concur for sale? Hot Stock Minute
08:30AM  Infinity Pharmaceuticals Inc and AbbVie to Discuss Strategic Collaboration In Oncology Call scheduled for 8:30 am ET today CCBN
07:49AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financia EDGAR Online
07:47AM  [$$] Infinity, AbbVie to Develop Cancer Treatment at The Wall Street Journal
07:37AM  Infinity Pharmaceuticals shares soar after AbbVie collaboration at MarketWatch
06:57AM  Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership at TheStreet
06:45AM  Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology PR Newswire
06:45AM  Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology Business Wire
06:30AM  Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche Business Wire
Aug-27-14 08:00AM  Infinity to Participate in Two Conferences in September Business Wire
Aug-25-14 11:41AM  Markets Open Higher; Burger King In Talks To Buy Tim Hortons Benzinga
Aug-11-14 08:30AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-06-14 11:35AM  Traders see no going back for Infinity optionMONSTER +7.82%
07:47AM  3 Stocks Under $10 Making Big Moves at TheStreet
Aug-05-14 08:15AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online +6.74%
08:00AM  Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update Business Wire
07:07AM  Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
Aug-04-14 04:43PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financia EDGAR Online
04:05PM  Infinity Amends PI3K-Delta, Gamma Agreement with Millennium Business Wire
Jul-24-14 08:00AM  Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast Business Wire
Jul-22-14 08:21AM  Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day Business Wire
Jul-07-14 02:54PM  3 Small-Cap Biotechs That Institutions Are Loving Benzinga -5.84%
Jul-01-14 03:25PM  Gilead Sciences Inc.'s Upcoming Catalyst(s) at Motley Fool
Jun-19-14 04:08PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-16-14 08:47AM  Five Biotech Stocks With Big Potential And Billionaire Believers at Forbes
Jun-03-14 08:00AM  Infinity to Present at the Goldman Sachs 35th Annual Global Healthcare Conference Business Wire
May-27-14 08:00AM  Infinity to Participate in Four Conferences in June Business Wire +5.53%
May-15-14 08:35AM  Gilead study 'alarming,' says Stifel at theflyonthewall.com -5.10%
May-08-14 04:20PM  Infinity Pharma Down on Wider-than-Expected Loss Zacks
May-07-14 07:52AM  Infinity Pharmaceuticals upgraded to Buy from Hold at Jefferies at theflyonthewall.com
May-06-14 04:30PM  Infinity Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:19PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
04:00PM  Infinity Reports First Quarter 2014 Financial Results and Provides Company Update Business Wire
03:57PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q1 2014 Infinity Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
Apr-30-14 08:00AM  Infinity to Participate in 3 Upcoming Conferences Business Wire
Apr-28-14 09:50AM  Drugs That Disappointed Investors In 2013: Infinity's IPI-145 at Seeking Alpha
Apr-24-14 08:00AM  Infinity Announces the Date of Its First Quarter 2014 Financial Results Conference Call and Webcast Business Wire
Mar-11-14 04:07PM  Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors Business Wire
Mar-10-14 05:28PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an EDGAR Online
04:00PM  Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors Business Wire
Mar-03-14 08:00AM  Infinity to Present at the Upcoming Bernstein Emerging Biotech Conference Business Wire
Feb-26-14 10:20AM  Infinity Pharma Rises on Narrower-than-Expected Loss Zacks
06:30AM  Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session Zacks
Feb-25-14 01:19PM  Why Infinity Pharmaceuticals Inc. Shares Jumped at Motley Fool +15.52%
12:05PM  Infinity Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:14AM  Show of support for Infinity Pharma optionMONSTER
08:30AM  Infinity Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:12AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations EDGAR Online
08:00AM  Infinity Provides Company Update and Reports Full-Year 2013 Financial Results Business Wire
07:51AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
07:07AM  Q4 2013 Infinity Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
Feb-19-14 08:00AM  Infinity to Participate in 3 Upcoming Conferences Business Wire
Feb-11-14 08:00AM  Infinity Announces the Date of Its Full-Year 2013 Financial Results Conference Call and Webcast Business Wire
Feb-10-14 05:01PM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Temporary Suspension of Trading Under Registrant's Employee Benefi EDGAR Online +5.35%
Feb-04-14 08:16AM  INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial EDGAR Online
08:00AM  Infinity Announces Promotion of David A. Roth to Chief Medical Officer Business Wire
Jan-23-14 04:03PM  Infinity reports Phase 1 data of IPI-145 clinically active in patients at theflyonthewall.com
Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to people with difficult-to-treat diseases. Its lead product candidate includes IPI-145, an oral inhibitor of Class I delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) for the treatment of hematologic malignancies and inflammatory diseases. The company is conducting DUOTM, a randomized, monotherapy Phase 3 study of IPI-145 in patients with relapsed/refractory chronic lymphocytic leukemia; an ongoing Phase 1 dose-escalation study to evaluate the safety, pharmacokinetics, and clinical activity of IPI-145 in patients with advanced hematologic malignancies; a Phase 2 study to evaluate the efficacy, safety, and pharmacokinetics of IPI-145 in patients with rheumatoid arthritis; and a Phase 2a trial of IPI-145 in patients with mild allergic asthma, as well as completed a Phase 1 trial of IPI-145 in healthy adult subjects. It also develops IPI-443, an oral inhibitor of PI3K-delta and gamma; and IPI-940, an inhibitor of fatty acid amide hydrolase. The company has strategic collaboration with AbbVie Inc. to develop and commercialize duvelisib (IPI-145) in oncology. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Palombella Vito J.Chief Scientific OfficerDec 15Option Exercise2.044,7379,6634,737Dec 16 07:44 PM
Palombella Vito J.Chief Scientific OfficerDec 15Sale16.324,73777,2940Dec 16 07:44 PM
Palombella Vito J.Chief Scientific OfficerNov 26Option Exercise2.044,7369,6614,736Nov 28 04:15 PM
Palombella Vito J.Chief Scientific OfficerNov 26Sale15.004,73671,0400Nov 28 04:15 PM
EVNIN ANTHONY BDirectorOct 03Option Exercise12.5624,500307,76591,900Oct 06 04:06 PM
EVNIN ANTHONY BDirectorSep 30Sale13.56112,4511,525,2290Oct 02 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03Option Exercise2.049,47219,3239,472Sep 05 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03Sale15.399,472145,7740Sep 05 04:05 PM
Palombella Vito J.Chief Scientific OfficerJul 01Sale12.8787911,3130Jul 02 06:20 PM
SELBY NORMAN CDirectorMar 06Option Exercise8.872,50022,17510,000Mar 10 05:26 PM
Palombella Vito J.Chief Scientific OfficerFeb 25Option Exercise2.044,7369,6614,736Feb 27 04:05 PM
Palombella Vito J.Chief Scientific OfficerFeb 25Sale15.004,73671,0400Feb 27 04:05 PM
Palombella Vito J.Chief Scientific OfficerJan 02Sale13.5275310,1810Jan 06 04:30 PM